Signant Health Enters Definitive Agreement to Acquire Ametris
Summary
Signant Health has entered a definitive agreement to acquire Ametris (formerly ActiGraph), a global digital health solutions provider. The transaction is subject to customary regulatory approvals and closing conditions, and the companies will share more details upon completion. Signant frames the deal as a way to expand its software capabilities for clinical evidence generation across eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. The combined offering aims to strengthen support for traditional, virtual, and hybrid clinical trials and broaden Signant’s reach with sponsors and CROs.
Classifications
industries
No industries detected
applications
Data Management
AskAI Classifications
Labels
Clinical Trial Software
eClinical Software
Patient Engagement Software
Linked Companies
Signant Health
$100M to $250M
Ametris
$10M to $25M